awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52645823-007ADC69-D5AD-48AD-BA92-BF7A34C433F5
Q52645823-007ADC69-D5AD-48AD-BA92-BF7A34C433F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52645823-007ADC69-D5AD-48AD-BA92-BF7A34C433F5
The role of tumor microenvironment in resistance to anti-angiogenic therapy.
P2860
Q52645823-007ADC69-D5AD-48AD-BA92-BF7A34C433F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52645823-007ADC69-D5AD-48AD-BA92-BF7A34C433F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
269900a4f7e2f5e7660e1ea2e8bb861ffd198108
P2860
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.